In an adult with cellulitis, can Augmentin (amoxicillin‑clavulanate) be used as oral step‑down therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, Augmentin (amoxicillin-clavulanate) is an excellent option for oral therapy in adult cellulitis.

Augmentin is explicitly listed as a suitable oral antibiotic for typical cellulitis in the 2014 IDSA guidelines and can be used either as initial therapy or as step-down therapy after intravenous treatment 1.

Guideline-Based Recommendation

The IDSA guidelines specifically name amoxicillin-clavulanate among the appropriate oral antibiotics for typical cellulitis, alongside penicillin, amoxicillin, dicloxacillin, cephalexin, and clindamycin 1. This recommendation is based on the fact that most cases of typical (non-purulent) cellulitis are caused by β-hemolytic streptococci, which are well-covered by these agents.

Key Clinical Considerations

When to use Augmentin:

  • Typical cellulitis without purulent drainage, abscess, or ulceration
  • As initial oral therapy in patients who don't require hospitalization
  • As step-down therapy after clinical improvement on IV antibiotics
  • When broader coverage is desired compared to plain penicillin or amoxicillin

Duration: If clinical improvement occurs by day 5, a 5-day course is as effective as 10 days 1. This shorter duration applies when using Augmentin for uncomplicated cellulitis.

MRSA Coverage Not Needed

A critical point: MRSA coverage is generally unnecessary for typical cellulitis. The IDSA guidelines cite prospective data showing that β-lactams like cefazolin or oxacillin were successful in 96% of cellulitis cases, demonstrating that MRSA is an uncommon cause 1. Reserve MRSA coverage only for cellulitis with:

  • Penetrating trauma (especially IV drug use)
  • Purulent drainage
  • Concurrent MRSA infection elsewhere

Supporting Evidence

Recent research confirms amoxicillin-clavulanate's effectiveness. A 2019 retrospective study of 59 hospitalized patients with erysipelas or bacterial cellulitis found that amoxicillin-clavulanate was associated with the shortest hospital stay and least often required additional antibiotics 2. A 2022 review reaffirms that oral antibiotics including amoxicillin are sufficient for non-purulent cellulitis caused by β-hemolytic streptococci or methicillin-sensitive Staphylococcus aureus 3.

Practical Dosing

For adults, standard dosing is typically 875 mg/125 mg twice daily or 500 mg/125 mg three times daily, taken with food to minimize GI upset 4. The FDA label emphasizes taking it at the start of meals to reduce gastrointestinal intolerance and enhance clavulanate absorption.

Common Pitfall to Avoid

Do not add MRSA coverage (like TMP-SMX or doxycycline) routinely to Augmentin for typical cellulitis. A double-blind study showed that adding TMP-SMX to cephalexin provided no additional benefit in pure cellulitis without purulent features 1. This unnecessary combination increases cost, side effects, and resistance pressure without improving outcomes.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.